We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M Turnover 57.14%
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.62%
5 Year Est. Return
+129.91%
10 Year Est. Return
+554.84%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91
Avg Time Held
2.4 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.03T
$620M 2.43%
14,653,788
+266,624
+2% +$11.1M
2013 Q2
18 quarters
MSFT icon
2
Microsoft
MSFT
$3.89T
$317M 1.25%
3,707,140
-123,518
-3% -$10.1M
2013 Q2
18 quarters
AMZN icon
3
Amazon
AMZN
$2.57T
$312M 1.23%
5,340,800
+484,500
+10% +$26.7M
2013 Q2
18 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.44T
$302M 1.19%
5,771,900
+417,420
+8% +$21.2M
2015 Q4
8 quarters
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.45T
$260M 1.02%
4,939,380
+39,200
+0.8% +$2.02M
2015 Q4
8 quarters
JNJ icon
6
Johnson & Johnson
JNJ
$670B
$260M 1.02%
1,860,304
+142,757
+8% +$19.9M
2013 Q2
18 quarters
META icon
7
Meta Platforms (Facebook)
META
$1.61T
$257M 1.01%
1,454,106
-23,277
-2% -$4.11M
2013 Q2
18 quarters
CNH icon
8
CNH Industrial
CNH
$18.4B
$222M 0.87%
19,036,768
+880,727
+5% +$9.7M
2013 Q4
16 quarters
V icon
9
Visa
V
$772B
$213M 0.84%
1,868,091
+39,358
+2% +$4.35M
2013 Q2
18 quarters
INTC icon
10
Intel
INTC
$346B
$205M 0.8%
4,432,924
+348,692
+9% +$15.2M
2013 Q2
18 quarters
PEP icon
11
PepsiCo
PEP
$185B
$204M 0.8%
1,698,132
+434,094
+34% +$49.6M
2013 Q2
18 quarters
UNH icon
12
UnitedHealth
UNH
$368B
$200M 0.78%
905,615
-72,887
-7% -$15.4M
2013 Q2
18 quarters
ABBV icon
13
AbbVie
ABBV
$524B
$198M 0.78%
2,051,785
+234,158
+13% +$22.1M
2013 Q2
18 quarters
AXP icon
14
American Express
AXP
$215B
$198M 0.78%
1,992,402
+201,182
+11% +$19.2M
2013 Q2
18 quarters
QCOM icon
15
Qualcomm
QCOM
$180B
$192M 0.75%
2,993,599
-490,697
-14% -$29.8M
2013 Q2
18 quarters
AMGN icon
16
Amgen
AMGN
$254B
$191M 0.75%
1,096,539
+125,375
+13% +$22.2M
2013 Q2
18 quarters
PFE icon
17
Pfizer
PFE
$173B
$188M 0.74%
5,468,629
+461,694
+9% +$15.7M
2013 Q2
18 quarters
CSCO icon
18
Cisco
CSCO
$414B
$175M 0.69%
4,564,047
+143,769
+3% +$5.14M
2013 Q2
18 quarters
TMO icon
19
Thermo Fisher Scientific
TMO
$260B
$171M 0.67%
899,802
+127,568
+17% +$24.4M
2013 Q2
18 quarters
HON icon
20
Honeywell
HON
$69.8B
$166M 0.65%
1,194,679
+142,256
+14% +$19.1M
2013 Q2
18 quarters
XOM icon
21
ExxonMobil
XOM
$772B
$162M 0.64%
1,935,126
+66,911
+4% +$5.53M
2013 Q2
18 quarters
NVDA icon
22
NVIDIA
NVDA
$5.01T
$160M 0.63%
33,131,680
-747,600
-2% -$3.71M
2016 Q2
6 quarters
T icon
23
AT&T
T
$145B
$159M 0.63%
5,428,356
-154,968
-3% -$4.23M
2013 Q2
18 quarters
UNP icon
24
Union Pacific
UNP
$179B
$159M 0.62%
1,186,282
-120,177
-9% -$14.5M
2013 Q2
18 quarters
MRK icon
25
Merck
MRK
$370B
$154M 0.6%
2,868,660
+1,541,507
+116% +$85.5M
2013 Q2
18 quarters

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.